ISFP2024 (The 8th World Congress of the International Society for Fertility Preservation) ISFP2024 (The 8th World Congress of the International Society for Fertility Preservation)

Faculty

Amy L Winship
Monash Biomedicine Discovery Institute, Australia
Amy L Winship
Dr Amy Winship is a current Rebecca Cooper Foundation Al & Val Rosenstrauss Fellow at Monash University. She completed her PhD in 2015 at the Hudson Institute of Medical Research. During this time, she investigated cytokine regulation of placental development. In 2016 she was awarded a Cancer Council Victoria Fellowship to examine a therapeutic strategy for cytokine-mediated endometrial cancer progression and spread. Dr Winship relocated to the Monash Biomedicine Discovery Institute in 2017 after being awarded a NHMRC Peter Doherty Early Career Research Fellowship, to begin research with Dr Karla Hutt in the Ovarian Biology Laboratory. She is establishing an emerging reputation in the fields of ovarian biology and oncofertility. Furthermore, capitalising on her uterine and pregnancy expertise, she recently initiated her own research direction to evaluate the impacts of cancer therapies on the uterus and subsequent pregnancy.

DOI:10.1172/jci.insight.163704

Anastasia Kirillova
Royal Women’s Hospital, Australia
Anastasia Kirillova
Anastasia Kirillova, Ph.D., ESHRE certified clinical embryologist, works as a Laboratory Manager at the Royal Women's Hospital. She graduated from Lomonosov Moscow State University in 2012 and did her postgraduate research at the University of Vienna studying the evolution of gastrulation and the molecular mechanisms of embryonic axis formation. Anastasia is a recipient of several scientific grants and awards including the EMBO fellowship and is an author of more than 20 scientific papers (including PNAS, Development, Cells). Anastasia Kirillova is a board member of the international IVM group and serves as an editor of the Journal of Assisted Reproduction and Genetics (JARG). Anastasia strives for innovation bridging the gap between basic science and clinical practice. Her scientific interests lay in the areas of fertility preservation, oocyte rejuvenation, and in vitro oogenesis.
Catherine Poirot
Hôpital Saint Louis, Assistance Publique-Hôpitaux de Paris. Paris, France
Catherine Poirot
Catherine POIROT is Professor at Sorbonne Université (Paris, France) and works at Saint Louis Hospital (AP-HP) in Paris. She is a physician, reproductive biologist and is responsible for the fertility preservation program at Saint Louis Hospital (Paris, France). She is past President of the French GRECOT group (Research and Study Group on Ovarian and Testicular Cryopreservation).
Chie Watanabe
School of Nursing and Rehabilitation Sciences, Showa University, Japan
Chie Watanabe
POSITION and AFFILIATION
Professor
School of Nursing & Rehabilitation Sciences Department of Nursing
Showa University
EDUCATION
1996 B.A. in Nursing, Japanese Red Cross University
2012 Ph.D.in Health Science Graduate School of Medicine, The University of Tokyo
WORK EXPERIENCE
2020-presencs
Professor
School of Nursing & Rehabilitation Sciences Department of Nursing
Showa University, Kanagawa,Japan
2014-
Associate Professor
Department of Nursing, Faculty of Human Sciences, Sophia University, Tokyo, Japan
2012-  Assistant Professor of Breast Center, Showa University School of Medicine, Tokyo, Japan
2007-  Junior Associate Professor Faculty of Nursing, Jikei medical University, Tokyo, Japan
2003- Clinical research coordinator and Data manager, Department of Chemotherapy, Cancer Institute Hospital, Tokyo, Japan
1996- Registered Nurse at oncology unit, Japanese Red Cross Hospital , Tokyo, Japan
COMMITTEE SERVICE
・Director of Japanese Society of Cancer Nursing
・Director of Japan Society for Fertility Preservation
・Congress Chair of the 5th AYA Oncology Alliance Meeting
・Specially appointed director of Japanese Society of Japanese Breast Cancer Society
Claus Yding Andersen
University Hospital of Copenhagen, Denmark
Claus Yding Andersen
Claus Yding Andersen is Professor emeritus of Human Reproductive Physiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
He has headed a national program of cryopreservation of human ovarian and testicular tissue and is considered one of the pioneers in this field.
His major research contributions are ovarian endocrinology, oocyte maturation, cryopreservation of gonadal tissue and development of new principles for ovarian stimulation including the agonist trigger and novel approaches to luteal phase support.
He has published more than 470 papers (H-index: 92; >28.000 citations) and is Chief Editor on the Reproduction section of Frontiers in Endocrinology (IF 5.2).
Debra A Gook
Reproductive Services, Royal Women’s Hospital, Australia
Debra Gook
Dr Debra A Gook is Senior Research Fellow in Reproductive Services at the Royal Women’s Hospital, and holds an honorary position within the Department of Obstetrics and Gynaecology, University of Melbourne, Australia. For over three decades, she has been at the forefront of research into the cryopreservation of the human female gamete. She has presented and published widely on freezing of both mature human oocytes and human ovarian tissue and continues to play a key role in the development of this technology for clinical application.
Dror Meirow
Sheba Medical Center, School of Medicine, Tel Aviv University, Israel
Professor Dror Meirow is the director of the Morris Kahn Center for Fertility Preservation Division of Obstetrics and Gynecology, at Sheba Medical Center, Tel-Hashomer, Israel. He is a Professor at the Faculty of Medicine, Tel-Aviv University, Israel. Served as President of the International Society of Fertility Preservation (ISFP).
Eileen Manalo
TBD
Glenn L Schattman
Weill Medical College of Cornell University, USA
Hiroshi Okada
Dokkyo Medical University, International Center for Reproductive, Japan
Hiroshi Okada
Academic Career
1980 Graduate from Kobe University School of Medicine (Kobe Japan)
1985 PhD at Kobe University Graduate School of Medicine (Kobe Japan)
1992-2002 Lecturer, Department of Urology, Kobe University Graduate School of Medicine (Kobe Japan)
2002-2003 Associate Professor, Department of Urology, Kobe University Graduate School of Medicine (Kobe Japan)
2003-2007 Associate Professor, Department of Urology, Teikyo University School of Medicine (Tokyo Japan)
2007-2020 Professor and Chairman, Department of Urology, Dokkyo Medical University Saitama Medical Center (Koshigaya Japan)
2020-present Professor emeritus Dokkyo Medical University, Chief Director of the International Center for Reproductive Medicine (Koshigaya Japan)
Honor
2000 Clinical Research Award from the Japanese Urological Association
2008 Best Presentation Award from the Japanese Society for Sexual Medicine
2010 Good Presentation Award from the Japanese Society of Clinical Oncology
2024 Best Poster Award from the Japanese Urological Association
Jacques Donnez
SRI – Catholic University of Louvain, Bergium
Jacques Donnez
Jacques Donnez was born in Tournai (Belgium) on 16 July, 1947.
He studied at the Catholic University of Louvain.
He defended his PhD thesis in 1984, entitled “The fallopian tube: normal and pathological histophysiology”.
He became Full Professor and Head of the Department Gynaecology and Andrology in 1986.
He also founded the Academic Infertility Research Unit of the Catholic University of Louvain in 1986.
He has focused his research activities on three main topics: tubal infertility, endometriosis and finally, ovarian cryopreservation and transplantation.
He published over 800 original articles in peer-review journals.
Prof. Donnez was the founding president of ESGE (European Society of Gynecological Endoscopy) and the first president of WES (World Endometriosis Society) Prof. Donnez was the first President of the International Society for Fertility Preservation (ISFP).
He has been elected in February 2009 at the Royal Belgian Academy of Medicine.
Since 2012, he is Professor Emeritus at the Catholic University of Louvain and Director of SRI (Société de Recherche pour l’Infertilité) in Brussels.
Member of several SAB (Scientific Advisory Boards), he is still involved in several clinical international multicenter studies on endometriosis and uterine fibroids, and collaborates with the Academic Unit of Prof. M.M. Dolmans, project leader and pioneer in the field of fertility
preservation in women.
Jana Bender-Liebenthron
University Gynaecological Clinic Duesseldorf, Germany/University Cryobank for Assisted Reproductive Medicine and Fertility Protection Duesseldorf, UniCareD, Germany
Jana Bender-Liebenthron
I am an expert in embryology and a qualified reproductive biologist. My specialisation is the preservation of female fertility, specifically the cryopreservation of ovarian tissue for medical reasons, mainly related to oncology diseases. I provide support to national and international institutions in this field through lectures, education, and professional consulting with confidence and authority. I am the Vice-Chairwomen of the FertiPROTEKT network association and member, consultant, and official cooperator of the 'Fertility Protection Project FPP' at Beijing Obstetrics and Gynecology Hospital, Capital Medical University in Beijing, China, and a founding and board member of the German-Chinese Society of Gynecology and Obstetrics (DCGGG). Additional I am a member of several professional organizations, such as the German Society of Gynecology and Obstetrics (DGGG), the European Society of Human Reproduction and Embryology (ESHRE), the German Society for Reproductive Medicine (DGRM), and the German Society for Reproductive Biology (AGRBM). As an expert reviewer in the field of professional accreditations for IVF laboratories in Switzerland, I am committed to improving the delivery of reproductive care to patients and redefining modern inperson care. I participate actively in numerous national and international congresses and continuing education events as an organizer, speaker, and moderator. Furthermore, I regularly publish scientific articles, reports in professional journals, and book contributions to share my expertise and advance the field.

DOI:10.1093/humrep/deac225

DOI:10.1016/j.fennstert.2021.03.008

DOI:10.1007/978-1-0716-0783-1 23

DOI:10.1016/j.rbmo.2019.01.006

DOI:10.1093/humrep/dew165

Jennifer J. Mueller
Memorial Sloan Kettering Cancer Center, USA
Jennifer J. Mueller
A. EDUCATION
Academic Degree(s)
B.A. Women Studies
University of Maine, Orono ME 09/1996-05/2002 Year Awarded 2002
M.D.
University of Vermont, Burlington VT 06/2004-06/2008 Year Awarded 2008
B. POSTDOCTORAL TRAINING
Residency, Obstetrics and Gynecology
Maine Medical Center, Portland, ME 07/2008 - 06/2012
Fellowship, Gynecologic Oncology
Memorial Sloan Kettering Cancer Center, New York NY 07/2012 - 06/2016
C. PROFESSIONAL POSITIONS & EMPLOYMENT
Academic Appointments
Assistant Member, Gynecology Service, Department of Surgery
Memorial Sloan Kettering Cancer Center, New York NY 09/2016 - present
Assistant Professor, Obstetrics and Gynecology
Weill Cornell Medical College, New York NY 12/2016 - present
Hospital Appointments
(This includes appointments at Memorial Hospital for Cancer and Allied Diseases including Instructor and those with the word “Attending” as well as other current or prior hospital appointments)
Assistant Attending, Gynecology Service, Department of Surgery
Memorial Hospital for Cancer and Allied Diseases, New York NY 09/2016 - present
Jesús Cadenas
Laboratory of Reproductive Biology, University Hospital of Copenhagen, Rigshospitalet, Denmark
Jesús Cadenas
Dr. Jesús Cadenas, a native of Almeria, Spain, is a researcher at The Laboratory of Reproductive Biology, University Hospital of Copenhagen, Denmark. He has an MSc in Biology and Technology of Reproduction from the University of Murcia in Spain and a PhD in Veterinary Sciences specializing in Reproductive Biology from the State University of Ceara in Brazil. His research focuses on three core areas: unraveling the regulation of human oocyte maturation, developing a platform able to efficiently sustain human oocyte maturation in vitro (known as IVM), and developing culture systems for human preantral follicles aiming to reproduce ovarian function in vitro. He has published 37 research articles in peer-reviewed journals and has an h-index of 13, according to Google Scholar.

DOI:10.1016/j.fertnstert.2023.01.027

Jung Ryeol Lee
Seoul National University College of Medicine, Korea
Jung Ryeol Lee
Professor Jung Ryeol Lee graduated from the Seoul National University College of Medicine, where he also earned his Ph.D. Following this, he completed his residency and fellowship at Seoul National University Hospital and Seoul National University Bundang Hospital. He is currently a professor at Seoul National University College of Medicine and Seoul National University Bundang Hospital and serves as the chairman of his department.
Professor Lee has conducted extensive research and published numerous articles in the areas of fertility preservation, minimally invasive surgery, assisted reproductive technologies, and fertility regeneration. His main academic interests are fertility preservation, regeneration and anti-aging in reproduction, minimally invasive surgery, and digital medicine. He is recognized as a leading figure among Korean clinicians and researchers in fertility preservation, reproductive endocrinology, and infertility. He is also a leading surgeon in the field of minimally invasive surgery, including single-port laparoscopic and robot-assisted surgery.
In addition, Professor Lee has served as an associate editor and editor-in-chief for many international peer-reviewed journals, such as Human Reproduction, Frontiers in Endocrinology, and Journal of Menopausal Medicine. As a board or council member, he has contributed to numerous International and Korean academic societies dedicated to reproductive endocrinology and fertility preservation.
Karla Hutt
Monash University, Australia
Karla Hutt
Professor Karla Hutt is an NHMRC Investigator, Deputy Head (Reseach) of the Department of Anatomy and Developmental Biology and co-Head of the Development and Stem Cells Discovery Program at Monash University. She obtained her PhD from the Australian National University in 2006, where her studies focussed on understanding ovarian development. She then undertook her postdoctoral studies at the University of Kansas Medical Center (USA), investigating the impact of environmental toxicants on oocyte and embryo quality. In 2008 she returned to Australia to work with Professor Jock Findlay as an NHMRC Peter Doherty Fellow. She was subsequently awarded an NHMRC CD1 Fellowship and joined the Department of Anatomy and Developmental Biology at Monash University in 2015, where she now leads the Ovarian Biology Laboratory. Her lab investigates the biological, cellular and molecular mechanisms underlying the loss of oocyte number and quality associated with reproductive aging, contaminated environments, cancer treatment and infection. Her goal is to use these insights to develop innovative strategies to protect the ovary from damage and preserve optimal fertility. Her research is supported by grants and fellowships from the ARC, NHMRC, NBCF and CCV.
Kathryn McFadden
November 2021 – January 2024, Paediatric Oncofertility Nurse Coordinator, The Royal Children’s Hospital, Melbourne, Australia
Kathryn McFadden
Mrs. Kathryn McFadden, RN, DipHE (Children’s Nursing)
Position:
Registered Nurse
Affiliation:
November 2021 – January 2024, Paediatric Oncofertility Nurse Coordinator, The Royal Children’s Hospital, Melbourne, Australia
Title of lecture:
The role and current status of nurses in the area of Oncofertility in Australia
Bio:
Kathy is a paediatric nurse with 22 years’ experience in Newborn Intensive Care, Fertility and Immunisation nursing. During her 2 years as the Paediatric Oncofertility Nurse Coordinator at The Royal Children’s Hospital, Kathy’s role included consulting with patients and families introducing them to the oncofertility preservation program, overseeing and coordinating all care involved in fertility preservation for both pre and post pubertal patients including coordinating care between medical teams, theatre’s, ethics and external laboratories. Kathy also provided education to nurses, doctors and allied health care teams, wrote patient information sheets and assisted in updating the guidelines for paediatric oncofertility. In 2022 she formed the ANZCO Nurses Network for nurses in both Australia and New Zealand with an interest in oncofertility.
In 2022, Kathy was awarded a research grant from the Murdoch Children’s Research Institute (MCRI) which she used to look at the difference in patient care with and without a dedicated oncofertility nurse.
Currently, Kathy and her family are travelling around Australia.
Katushiko Hayashi
Osaka University, Graduate School of Medicine, Japan
Katushiko Hayashi
2004 PhD, (Science, Tokyo University of Science)
2004-2005 Researcher, Osaka Women’s and Children’s Hospital.
2005-2009 Postdoctoral fellow, Gurdon Institute, University of Cambridge
2009-2014 Associate Professor, Graduate School of Medicine, Kyoto University
2014-2021 Full Professor, Graduate School of Medical Sciences, Kyushu University
2021-present Full Professor, Graduate School of Medicine, Osaka University
Kenny A. Rodriguez-Wallberg
Karolinska Institutet and Karolinska University Hospital, Sweden
Kenny A Rodriguez-Wallberg
Kenny A. Rodriguez-Wallberg, MD, PhD is Professor of Reproductive Oncology at Karolinska Institutet in Stockholm, Sweden. She is also consultant at the Department of Reproductive Medicine of Karolinska University Hospital and Head of the Clinical Program of Fertility Preservation.
A reproductive medicine specialist by training, her research focuses on how cancer treatments impact young patients’s reproductive health and on the safety and efficacy of the procedures for fertility preservation. She has published extensively in reproductive medicine topics including assisted reproductive technologies, fertility preservation in adults, adolescents and children, obstetrical outcomes and specific risks in patients with cancer or benign conditions, transgender reproductive issues, reproductive endocrinology, genetics and menopause. Her research encompasses clinical, epidemiological and translational research and she is the Head of the Laboratory of Translational Fertility Preservation at Karolinska Institutet.
For the past 20 years, her work has focused on fertility preservation. Dr. Rodriguez-Wallberg has published more than 150 peer-reviewed papers.
Website: https://ki.se/en/onkpat/research-team-kenny-rodriguez-wallberg

DOI:10.1016/j.eclinm.2023.102335

DOI:10.1136/bmjopen-2023-078023

Kouichi Kyono
Human Ovarian-tissue Preservation Enterprise (HOPE), Japan
Kouichi Kyono
Dr. Koichi KYONO
-President and CEO of
Kyono ART Clinic Sendai in Miyagi
Kyono ART Clinic Takanawa in Tokyo
Kyono ART Clinic Morioka in Iwate
Kyono ART Clinic Shinagawa/ Human Ovarian-tissue Preservation Enterprise (HOPE) in Tokyo
LICENSURE
Board Certified Trainer & Fellow of Japan Society of Obstetrics and Gynecology
Board Certified Trainer & Fellow of Japan Society for Reproductive Medicine
Designated physician on Maternal Protection Act Japan
Cancer and reproductive medicine navigator certified by Japan Society for Fertility Preservation
POSITION & HONORS
Director, General Incorporated Association for the Advancement of Ovarian Tissue Cryopreservation / Director, Japanese Institution for Standardizing Assisted Reproductive Technology (JISART) /
Director, Japan Reproductive Health Association /
Director, Japan Society for Repro-Developmental Medicine /
Director, Japan Reproductive Health Association
Recommended for Distinguished Member, Japan Society for Reproductive Medicine /
Distinguished Member, Japanese Society for Ova Research /
Ethics Committee Member, Japan Society of Fertilization and Implantation / Advisor, Reproductive Biology Tokyo Symposium
EDUCATION & ACHIEVEMENTS
He graduated from Fukushima Medical College, receiving his MD in 1978 and his Ph.D. in 1985 in Obstetrics and Gynecology (reproductive biology) at Tohoku University. He was a member of the Tohoku University team that succeeded in the first IVF pregnancy and delivery in Japan in 1983. He also succeeded in the first birth following frozen-thawed oocytes by slow-freezing in Japan in 2001. Now he operates IVF clinics in Morioka, Sendai and Tokyo and has a center for fertility preservation in Tokyo.

DOI:10.1007/s12522-013-0166-9 Kyoya

DOI:10.1007/s10815-017-1022-3 Kyono

DOI:10.1016/j.fertnstert.2009.08.031 Kyono Potential indication

DOI:10.1023/a:1016350522086 Kyono IVM

DOI:10.1142/S2661318221500031 Hattori IVM follow up

DOI:10.1023/B:JARG.0000046206.60981.9c Fuchinoue IVM

DOI:10.1016/j.fertnstert.2005.04.051 Kyono Oocyte vitrification

DOI:10.1016/j.rbmo.2020.11.005 Takeshige oocyte vitrification follow up RMB

DOI:10.1142/S2661318220500140 Nakamura ALL oocyte vit Two birth

DOI:10.1016/j.rbmo.2017.05.016 Nakamura Residual cryoprotectants

DOI:10.11412/jspho.58.118 The Japanese Society of Hematology/ Oncology Transportation

DOI:10.1274/jmor.33.115 Kyono Review before OTT

DOI:10.1274/jmor.27.101 Sankai Ovary cryopreservation

DOI:10.1274/jmor.30.101 Ovary cryopreservation

DOI:10.1142/S2661318223500056 18.3 years embryo Okuyama

Kutluk H Oktay
Yale University School of Medicine, Department of Obstetrics, Gynecology, and Reproductive Sciences & Innovation Institute for Fertility Preservation, USA
Kutluk H Oktay
Curriculum Vitae, Kutluk Oktay, MD, Ph.D, FACOG March 22, 2024
M.D. DEGREE
Hacettepe University Medical School, Ankara, Turkey 9/2/1980 – 7/31/1986
SPECIALTY TRAINING
Internal Medicine
Marmara University Hospital, Istanbul 12/1/1986 – 3/15/1988
Cook County Hospital, Chicago 7/1/1988 – 6/30/1989
Obstetrics & Gynecology
Columbia University College of Physicians & Surgeons, Harlem Hospital Center, NY 7/1/1989 – 6/30/1991
University of Connecticut Health Center 7/1/1991 – 6/30/1993
SUBSPECIALTY TRAINING
Reproductive Endocrinology & Infertility University of Texas HSC at San Antonio 7/1/1993 – 6/30/1995
RESEARCH FELLOWSHIP
ACOG-RCOG (Well-Being) UK Research Fellowship
University of Leeds School of Medicine, Division of 7/15/1995 – 8/31/1996
Reproductive Biology, Dept. Obstetrics & Gynecology Leeds, United Kingdom
PhD STUDIES:
University of Ghent, Belgium (remote study) 11/1/2012 – 9/21/2015
BOARD EXAMS & CERTIFICATION
Reproductive Endocrinology & Infertility 03/31/1999
American Board of Obstetrics & Gynecology 11/07/1997
ABC recertification 2007-2012
Da Vinci Robotic Surgery certification 11/05/2009
ABC Recertification (Written test and ABC) 09/18/2013
ABC recertification 2014-present
Curriculum Vitae, Kutluk Oktay, MD, Ph.D, FACOG March 22, 2024
ACTIVE MEDICAL LICENSURE
State of Connecticut 10/23/1992 - present
State of New York 12/17/1997 - present
State of Minnesota 05/23/2019 - present
CLINICAL PRACTICE
Founder & Director, Innovation Institute for Fertility Preservation 4/01/2013 - present
ACADEMIC & ADMINISTRATIVE APPOINTMENTS
Adjunct Professor of Obstetrics & Gynecology, NYU Langone Long Island School of Medicine, Mineola, NY 2/21/2019 – present
Professor of Obstetrics & Gynecology, Department of OB/GYN and Reproductive Sciences, Yale University School of Medicine, New Haven, CT 8/14/2017 – present
Director, Ovarian Transplant Program
NYU-Winthrop Hospital, Mineola, NY 8/14/2017–present
Vice Chair of Research, Department of Obstetrics & Gynecology, New York Medical College (NYMC) 11/01/15 – 8/13/17
Senator, Faculty Senate, New York Medical College 9/01/15 – 8/13/17
Member, Faculty Council, Graduate School of Basic Medical Sciences, New York Medical College 08/01/10 – 8/13/17
Member, Postgraduate School of Medical Sciences, NYMC 10/01/09 – 8/13/17
Professor of Pathology
New York Medical College, Valhalla, NY 10/01/12 – 8/13/17
Professor of Cell Biology & Anatomy
New York Medical College, Valhalla, NY 10/01/09 – 8/13/17
Professor of Medicine
New York Medical College, Valhalla, NY 10/01//09 – 8/13/17
Professor of Obstetrics & Gynecology
New York Medical College, Valhalla, NY 10/01//08 – 8/13/17
Curriculum Vitae, Kutluk Oktay, MD, Ph.D, FACOG March 22, 2024
Director, Division of Reproductive Medicine
Department of Obstetrics & Gynecology New York Medical College, Valhalla, NY 01/01/08 – 8/13/17
Consultant Physician, Department of Surgery
Memorial Sloan Kettering Cancer Center 06/18/08 – 06/31/2010
Associate Professor of Obstetrics & Gynecology
Department of Obstetrics & Gynecology
Weill Medical College of Cornell University 09/16/2003 - 12/31/2007
Director, Division of Reproductive Endocrinology
Department of Obstetrics & Gynecology
New York Methodist Hospital Brooklyn, NY 10/01/1996 - 08/31/2000
Assistant Professor of Obstetrics & Gynecology
Department of Obstetrics & Gynecology
Weill Medical College of Cornell University
New York, NY 09/15/1997- 09/15/2003
Assistant Professor of Obstetrics & Gynecology
Department of Obstetrics & Gynecology
State University of New York at Brooklyn
Brooklyn, NY 09/01/1996 – 08/31/1997
HOSPITAL APPOINTMENTS
Greenwich Hospital, Greenwich, CT (Yale Health) Pending
Yale New Haven Hospital, New Haven, CT 02/04/2021 (courtesy)01/04/2022- present (full)
NYU Langone Medical Center, NY, NY 08/05/2019 - present
NYU Winthrop Hospital (now NYU Langone Long Island Hospital), Mineola, NY 08/09/2017 - present
Westchester Medical Center, Valhalla, NY 01/01/2008 - 5/31/2019
Memorial Sloan Kettering Hospital, NY, NY (consultant) 06/18/2008 - 06/31/2010
New York Hospital-Cornell, NY, NY 09/01/2000 -12/31/2007
New York Methodist Hospital, Brooklyn, NY 09/15/1997 -10/01/2000

DOI:10.1016/j.ajog.2023.12.037

DOI:10.1016/j.fertnstert.2023.10.015

DOI:10.1016/j.ajog.2023.08.032

DOI:10.1016/j.fertnstert.2022.08.005

DOI:10.1016/j.fertnstert.2021.08.034

DOI:10.1007/s10815-021-02297-9

DOI:10.1016/j.molmed.2021.01.005

Kyle E Orwig
University of Pittsburgh, USA
Kyle Orwig
Dr. Orwig is a Professor of Obstetrics, Gynecology and Reproductive Sciences at the University of Pittsburgh School of Medicine. He is also the director of the Fertility Preservation Program and the Center for Reproduction and Transplantation at Magee-Womens Hospital of UPMC. Research in the Orwig laboratory focuses on stem cells, germ lineage development, fertility and infertility. Our progress investigating reproductive function in fertile individuals provides a basis for understanding the mechanisms of infertility caused by disease, medical treatments, genetic defects or aging. Infertility impacts one in seven couples in the United States and can have a devastating impact on relationships, emotional well-being and overall health. The Orwig lab is ideally located in Magee-Womens Research Institute and Magee-Womens Hospital of the University of Pittsburgh and is committed to translating lab bench discoveries to the clinic for diagnosis, prevention and treatment of infertility.
Fertility Preservation Program in Pittsburgh http://www.fertilitypreservationpittsburgh.org
Orwig Research Group http://www.orwiglab.org
Luciana Cacciottola
Université Catholique de Louvain, Belgium
Luciana Cacciottola
Current position
Postdoctoral researcher. Gynecology Research Unit, Université Catholique de Louvain (UCL), Brussels (Belgium)
Work history
2018 - present Gynecology Research Unit, UCL, Brussels (Belgium)
Research
• Aging mechanisms in human ovarian tissue and causes of acceleration of senescence
• Investigation of mechanisms of iatrogenic damage to the ovary and uterus
• Fertility preservation in young women with borderline ovarian tumors
Clinics
• Clinical counseling for benign gynecological pathologies, gynecological endocrinology, infertility and oncofertility
• Diagnostic: gynecological ultrasound, office hysteroscopy and colposcopy
2013 – 2018 Macedonio Melloni Hospital, Università degli Studi di Milano (Italy)
Resident in gynecology and obstetrics. Clinical and surgical activity, with a special interest in infertility and assisted reproductive techniques, gynecological endocrinology and oncofertility.
2016 - 2017 Gynecology Research Unit, UCL, Brussels (Belgium)
Internship in research. Development of an in vivo method to investigate oxidative stress in human transplanted ovarian tissue.
2011 – 2013 Infertility and Assisted Reproductive Techniques Center, Macedonio
Melloni Hospital, Università degli Studi di Milano (Italy)
Clinical internship. Diagnosis, counseling and treatments for infertility.
Education
2018 – 04/22 PhD in health science, UCL, Brussels (Belgium). Thesis title: Improving ovarian tissue transplantation using adipose tissue-derived stem cells.
2013 - 2018 Specialization in gynecology and obstetrics, Università degli Studi di Milano (Italy). Score: 70/70 cum magna laude.
2006 - 2012 Master’s degree in medicine, Università degli Studi di Milano (Italy). Score: 110/110 cum magna laude.
2001 - 2006 Scientific upper secondary school diploma, Liceo scientifico Leonardo da Vinci, Milan (Italy). Score: 95/100.

DOI:10.1093/hropen/hoad040

DOI:10.1016/j.rbmo.2021.06.019

DOI:10.1016/j.fertnstert.2021.03.008

Malene L. Johannsen
Rigshospitalet, Denmark
Malene L. Johannsen
Present position
2022.09 - Ph.D Student at the Laboratory of Reproductive Biology, Rigshospitalet, Denmark
Title: Ovarian steroidogenesis: Regulation of theca- and granulosa cell function in humans
Education
2018 Msc in Pharmacy, University of Copenhagen, Denmark
Master’s Thesis title: Endocrine disrupting effects of GABAA receptor agonists
2016 investigated in vitro using H295R steroidogenic assay and a recombinant CYP17 assay.
Bsc in Pharmacy, University of Copenhagen, Denmark
2010 High School diploma, Duborg Skolen, Flensburg, Germany
Work Experience
2021.09 – 2022.08 Research Assistant, translational Drug Metabolism and Pharmacokinetics, Lundbeck
2019.01 – 2021.06 Research Assistant, Department of Pharmacy, University of Copenhagen
2018.10 – 2018.11 Internship, Toxicology and Drug Metabolism Group, Department of Pharmacy, University of Copenhagen
Marie-Madeleine Dolmans
Universite Catholique De Louvain, Belgium
Marie-Madeleine Dolmans
Prof. Marie-Madeleine Dolmans earned her medical degree from the Université
Catholique de Louvain in Brussels in 2000, and her PhD degree on “Cryopreservation and transplantation of human ovarian tissue” in 2006. She is gynecologist and divides her time equally between clinical and research activities. She succeeded Prof. Donnez as Head of the Gynecology Research Unit at the Université Catholique de Louvain in 2012. She is Past President of the International Society for Fertility Preservation (ISFP). Her research work focuses on ovarian transplantation, endometriosis and adenomyosis in the field of which she has published over 220 peer-reviewed articles. She is full professor, speciality editor for Fertility and Sterility and editorial board member for RBMonline, JARG, JCM..
Michael von Wolff
Inselspital Bern, Switzerland
Michael von Wolff
Michael von Wolff studied medicine in Germany and U.K. and worked in Germany, U.S. and Switzerland.
After being awarded a professorship in Heidelberg in 2007, he was appointed Head of Department of Gynecological Endocrinology and Reproductive Medicine at the University Women‘s hospital in Bern, Switzerland in 2009.
His current major research interests are fertility protection in cancer. In this context, he wrote and edited several books and founded the 3-country network FertiPROTEKT (www.Fertiprotekt.com) in 2006, the ESHRE Task Force Fertility Preservation in 2007 and co-founded the ESHRE-SIG Fertility Preservation. He is board member of the International Society for Fertility Preservation, ISFP.
Furthermore, he specialized clinically and scientifically in Natural Cycle and Minimal stimulation IVF and founded the international network IVF-Naturelle (www.ivf-naturelle.com).
Michel L.L.H. De Vos
Brussels IVF, UZ Brussel, Brussels, Belgium/Free University of Brussels (VUB), Brussels, Belgium
Michel L.L.H. De Vos
Michel De Vos is a senior medical director at Brussels IVF, the Centre for Reproductive Medicine at Universitair Ziekenhuis Brussel, Belgium and an associate professor at Vrije Universiteit Brussel.
He studied medicine in Ghent, Belgium (MD 1997), has been a gynaecologist since 2006 and holds a PhD in medicine from the University of Leeds, United Kingdom (2007). In 2011, he was certified as a subspecialist in reproductive medicine and surgery by ESHRE and the European Board and College of Obstetrics and Gynaecology (EBCOG). His main research focus is on fertility treatment in women with polycystic ovary syndrome and on fertility preservation. He is the past Chair of the In Vitro Maturation Special Interest Group of the ASRM.
He is a member of the Female Oncofertility Scientific Committee of The Oncofertility Consortium of Michigan State University and a founding member of the Belgian division of the International Reproductive Health Education Collaboration (IRHEC).
Dr De Vos is an associate editor of Human Reproduction. He has authored more than 200 scientific publications (Web of Science).

DOI:10.1007/s10815-021-02263-5

Monica M Laronda
Ann & Robert H. Lurie Children’s Hospital of Chicago, Northwestern University, Chicago, IL USA
Monica Laronda
Monica M. Laronda is the Director of Research for the Fertility & Hormone Preservation & Restoration Program at the Ann & Robert H. Lurie Children's Hospital of Chicago. She is the Gesualdo Family Research Scholar at the Stanley Manne Children's Research Institute and Assistant Professor in the Department of Pediatrics and Department of Obstetrics and Gynecology at Northwestern University. She has been awarded several National Institutes of Health grants to study foundational biology and to engineer regenerative techniques for both ovaries and testes.

DOI:10.1016/j.xfre.2023.02.008

DOI:10.1038/s41598-019-56454-3

Nalini Kaul Mahajan
Mother & Child Hospital, New Delhi, India
Nalini Kaul Mahajan
She did her graduation and MD (OBGYN) from Delhi University and attained a master’s in ART from Nottingham University UK. She has been practicing ART for over 25 years. Her special interests in ART lie in the field of ‘Fertility Preservation’, ‘Endometrial Receptivity’ and ‘Poor Ovarian Reserve’. She founded the Fertility Preservation Society of India in 2014 and spearheaded the campaign for oncofertility awareness amongst physicians and paramedical staff in India under the aegis of FPSI. Keeping in context the ethnic, social and economic differences in India the FPSI under her leadership published the ‘Recommendations for Clinical Practice of FP for Patients on Gonadotoxic therapy’ for Indian physicians.
She has published numerous research papers and written chapters for several books on ART.
Nao Suzuki
Department of Obstetrics and Gynecology, St. Marianna University School of Medicine/St. Marianna University Hospital, Japan
Nao Suzuki
EDUCATION
1981-1983 Keio High School, Kanagawa, Japan, cum laude
1984-1990 M.D., School of Medicine, Keio University, Tokyo, Japan
1993-1997 Ph.D. in Obstetrics and Gynecology, Graduate School of Medicine,
Keio University, Tokyo, Japan: Supervisor: Professor Shiro Nozawa
MEDICAL LICENSE
Apr 1990 Passed national medical board examination and licensed to practice medicine in Japan
POST-GRADUATE MEDICAL TRAINING IN OBSTETRICS AND GYNECOLOGY
1990-1991 Keio University Hospital, Tokyo, Japan
1991-1992 The Saiseikai Utsunomiya Hospital, Tochigi, Japan
1992-1993 Tokyo Dental College General Hospital, Chiba, Japan
POST-GRADUATE RESEARCH TRAINING
Apr 1996-Sep 1999
Visiting Post-Doctoral Research Fellow, The Burnham Institute: La Jolla, California, U.S.A.
Supervisor: Michiko N. Fukuda, PhD
EXPERIENCE IN OBSTETRICS AND GYNECOLOGY
2000-2005 Instructor at Keio University, School of Medicine, Tokyo, Japan
2005-2008 Assistant Professor at St. Marianna University School of Medicine, Kanagawa, Japan
2009-2010 Associate Professor at St. Marianna University School of Medicine, Kanagawa, Japan
2011-2012 Professor at St. Marianna University School of Medicine, Kanagawa, Japan
2012-present Professor and Chair at St. Marianna University School of Medicine, Kanagawa, Japan
2016-present Visiting Professor of Second Military Medical University, Shanghai, China
2019-present Visiting Professor of Northwest Women’s and Children’s Hospital Affiliated to Xi'an Jiaotong University, Xi’an, China
2021-present Honor Adviser, Multidisciplinary Team for Fertility Preservation in The First Affiliated Hospital of China Medical University, Liaoning, China
2022-present Adjunct Adviser, The Human Fertility Preservation Center of Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China
2022-present Visiting Professor at The Department of Obstetrics and Gynecology, Faculty of Medicine, Universiti Kebangsaan Malaysia, Malaysia
2022-present Distinguished Professor of The Third Affiliated Hospital of Zhengzhou University, Henan, China
PROFESSIONAL MEMBERSHIP
Japan Society of Obstetrics and Gynecology: Councilor
Japan Society of Gynecologic Oncology: Board Member
Japanese Society of Clinical Oncology: Board Member
Japan Society for Fertility Preservation: President
Kanagawa Society of Obstetrics and Gynecology: Board Member
AYA Oncology Alliance (Japan): Board Member
International Society for Fertility Preservation (ISFP): Board Member
Chinese Maternal and Child Health Association Fertility Preservation Society: Academic Adviser
Asian Society for Fertility Preservation (ASFP): Board Member, Former President (2016-2020)
Asian Society of Gynecologic Oncology: Council Member
Journal of Assisted Reproduction and Genetics (Journal): Editorial Board Member
Journal of Adolescent and Young Adult Oncology (Journal): Editorial Board Member
FIELD OF RESEACH
Gynecologic Oncology, Fertility Preservation for the CAYA cancer patients, Palliative Medicine, Psycho Oncology, Reproductive Medicine

DOI:10.1093/humrep/des178

Olivia Jaworek Frias
Cincinnati Childrens Hospital Medical Center, Comprehensive Fertility Care and Preservation Program, USA
Olivia Jaworek Frias
Olivia Jaworek Frias MSN, RN IV, CNL
Patient Navigator for Fertility Preservation
Comprehensive Fertility Care and Preservation Program
Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio
Olivia Jaworek Frias is the Patient Navigator for Fertility Preservation in the Comprehensive Fertility Care and Preservation Program (CFCPP) at Cincinnati Children’s Hospital Medical Center (CCHMC). Olivia received her bachelors in science of nursing at the University of Akron and masters in science of nursing at Xavier University. Olivia started her career caring for oncology and bone marrow transplant patients within the inpatient Cancer and Blood Disease Institute. She brought her expertise to the division of Pediatric and Adolescent Gynecology (PAG) at CCHMC, where her role as the patient navigator for fertility preservation transpired. Olivia is an integral piece to the fertility program, as she is the initial and main point of contact for patients and families. Olivia is globally recognized for her work within the Oncofertility Consortium, as she currently serves as the Chair for the Patient Navigation Scientific Committee. She continues to advocate for her patients/families around the world, through education, lectures, and research.
Oren Kashi
Fertility Preservation Center, Sheba Medical Center, Israel
Oren Kashi
Oren kashi is a researcher at the fertility preservation center at Sheba medical center, Israel. He completed his PhD at the Fertility Preservation Center, on the research of the chemotherapy effect on the ovarian reserve: He Assessed DNA sublethal damage in surviving oocytes following exposure to chemotherapy treatment, and in another research investigated the combined suppression of follicle activation through intrinsic and extrinsic pathways in oocytes, as a tool of protection against chemotherapy-induced ovarian reserve loss in mice. In his post-doctoral project, he investigated the mechanism of the loss of oocytes of primordial follicles exposed to chemotherapy using single cell RNAseq.

DOI:10.1093/humrep/dead064

DOI:10.3390/ijms242216291

Ozgur Oktem
Koc University Hospital, Turkey
Ozgur Oktem

Dr. Ozgur Oktem finished his residency in OB/GYN in 2001 at Marmara University Hospital, Istanbul, Turkey and completed postdoctoral fellowship at the Center for Reproductive Medicine and Infertility at Weill Medical College of Cornell University between 2003-2005, and molecular biology at Memorial Sloan Kettering Center 2005-2008 in New York, USA.
He is currently a clinician scientist professor of OB/GYN and Reproductive Medicine at Koc University Hospital and the co-director of reproductive medicine PhD program at the Graduate School of Health Sciences at Koc University, Istanbul Turkey.
His research is focused on fertility preservation, molecular mechanisms of chemotherapy-induced gonadal damage, luteal phase, corpus luteum biology, and steroidogenesis. His research studies were awarded by the Society of Gynecological Investigations 2008 USA, and the American Society of Reproductive Medicine (ASRM) in 2013, 2015 and 2016.

DOI:10.1093/humrep/deac242

Pasquale Patrizio
Division Reproductive Endocrinology and Infertility, Dept. Obstetrics/Gynecology and Reproductive Sciences, University of Miami, Miller School of Medicine, USA
Pasquale Patrizio
Dr. Pasquale Patrizio is a board-certified specialist in Obstetrics & Gynecology, Reproductive Endocrinology and Infertility, Andrology and has a Master in Bioethics. He is Professor of Obstetrics/Gynecology and Chief, Division Reproductive Endocrinology and Infertility and Program Director of the REI Fellowship at the University of Miami, Miller School of Medicine. He is Associate Editor for the Journal Assisted Reproduction and Genetics (JARG) and section editor for the American Journal of Obstetrics and Gynecology (AJOG) and Reproductive Biomedicine Online (RBMO). He was founding member of the International Society Fertility Preservation (ISFP) and President between 2015-2017. He has also served as Chair of the ASRM Fertility Preservation Special Interest Group between 2019-2020. Dr.Patrizio has authored 9 books, 638 scientific papers (96 book chapters, 242 peer-reviewed publications and 300 published abstracts) and holds 2 issued patents.
He is Honorary member of the Italian Society of Fertility and Sterility, Fellow of the International Academy of Human Reproduction and has received prize paper awards from both ASRM and ESHRE.
The most significant research and clinical innovation accomplishments include: Co-pioneering the technique of microsurgical epididymal sperm aspiration (MESA) for men with congenital absence of the vas deferens and discovered the etiology as a mild form of cystic fibrosis; Discovered that some cases of male infertility are due to Y-chromosome deletions; Pioneered the technique of whole ovary cryopreservation; Deciphered molecular mechanisms responsible for oocyte aging.
Current research interests include improving the efficiency and protocols of ART, reproduction at advanced age; simplify and standardize the IVF laboratory by automation; lyophilization of gametes, embryos and reproductive tissue; and enhancing fertility preservation strategies with ex-vivo ovarian perfusion.
Petra Stute
Inselspital Bern, Switzerland
Petra Stute
Prof. Dr. med. Petra Stute is a board-certified specialist of Obstetrics & Gynecology and Gynecological Endocrinology & Reproductive Medicine. She is associate professor at the University of Bern, Switzerland. She is the head of Gynecological Endocrinology and Menopause Centre at the University Clinic Inselspital Bern, Switzerland. She is currently the vice president of EMAS.
Richard Kwong Wai Choy
Department of Obstetrics and Gynaecology, The Chinese University of Hong Kong, Hong Kong
Richard Kwong Wai Choy
I am currently a Professor in the Department of Obstetrics & Gynaecology, and the founder of the Preimplantation Genetic Testing PGT) Laboratory and the Prenatal Genetic Diagnosis Centre (PGDC) at Chinese University of Hong Kong (CUHK), serving now as the Deputy Director in charge of laboratory services. The PGT and PGDC are both one of the most active and productive centers in Asia, serving as a tertiary referral and training center for PGT and prenatal testing for both the public and private clinical sectors in Hong Kong, mainland China and Asia. As a pioneer in PGT and prenatal diagnosis, my team utilizes state-of-the-art genomic technologies, including chromosomal microarray analysis (CMA) and genome sequencing, and we first reported the outcome of a multi-centre mosaic embryo transfer pregnancy outcome in Asia and the contribution of pathogenic chromosome copy number variants (CNVs) in fetus with high nuchal translucency. In 2021, I established the Fertility Preservation Research Centre to enhance the outcome of in-vitro fertilization pregnancies
My achievements include over 225 publications in international peer-reviewed journals, with several landmark papers uncovering the contribution of CNVs in fetuses with structural malformations, and an H-index of 44. Recently, my laboratory pioneered the novel application of Low-pass whole-genome sequencing (Low-pass WGS) method which can detect balanced chromosomal structural variants (SVs) or rearrangements that contribute to human diseases.
I received over 45 competitive research grants as PI or co-PI from Hong Kong UGC, NSFC in China, and NIH in US in a scale of 0.5 million to 35 million HKD, and a recent 10 million dollar donation for my work on reproductive genetics. In acknowledgment of my contributions to genetics, I received the Excellent Research Award from the Food and Health Bureau, an international Outstanding Contributions Award for Prevention and Control of Birth Defects and Excellence in Genetics Education Award by the Association of Chinese Geneticists in America (ACGA).
I have served as organizing committee member/scientific adviser/chairperson in seven international professional and academic meetings since 2010 including the Asia Pacific Congress in Maternal and Fetal Medicine, Vice-President of the Hong Kong Society of Genetics Counselling, Board of Director of the PGDIS and Board Member of the Hong Kong Society of Medical Genetics. In addition, I serve as editorial board member of Human Genetics and Prenatal Diagnosis. I have also provided consultancy service to the Industry on trials of new instruments and platforms intended for clinical laboratory service in and outside Hong Kong.

DOI:10.1016/j.ajhg.2019.10.003

DOI:10.3390/genes12040496

Ri-Cheng Chian
Shanghai 10th People’s Hospital of Tongji University, China
Ri-Cheng Chian
Professor Ri-Cheng Chian is Director at Center for Reproductive Medicine, Shanghai 10th People’s Hospital of Tongji University, P. R. of China. Before joining to the current position, Dr. Chian was an Associate Professor with Tenure at Department of Obstetrics and Gynecology, Faculty of Medicine, McGill University, Montreal, Canada.
Dr. Chian is the key person in the development of in vitro maturation (IVM) of human oocytes for clinical application and for cryopreservation of human oocytes which resulted in the first pregnancies and live births at McGill University Health Center (MUHC) in Canada.
Dr. Chian published more than 200 research papers in journals and gave presentations at many international/regional conferences. Dr. Chian edited three books and contributed to various book chapters. As an invited guest speaker, Dr. Chian delivered lectures in many different societies and countries.
Dr. Chian was a former Associate Editor for the journals, Human Reproduction, Journal of Assisted Reproduction & Genetics, and an Editorial Board Member for several other journals. Dr. Chian is an Associate Editor for the journal, Reproductive and Developmental Medicine.
Dr. Chian’s research interests are included:
1) Simplifying infertility treatment;
2) Fertility preservation.
Dr. Chian speaks English, Chinese, Korean, Japanese and has some knowledge of French.
Sanaz Dereh Haim Tzfanya
Fertility Preservation Center, Sheba Medical Center, Israel
Sanaz Dereh Haim Tzfanya
Sanaz Dereh Haim Tzfanya is a PhD student at Tel Aviv University and the Fertility Preservation Laboratory at Sheba Medical Center, Israel, under the supervision of Prof. Dror Meirow. Her PhD research investigates the Involvement of extra follicular compartment, including stromal cells and extra-cellular matrix, in primordial follicle activation. In addition, she is a member of team which investigates Minimal Residual Disease (MRD) in ovary before ovarian tissue transplantation in cancer patients. She has graduated from Bar Ilan university with MSc and B.A degrees.
Sherman J Silber
Silber Infertility Center of St. Louis, USA
Sherman J Silber
He performed the world’s first microsurgical vasectomy reversal, as well as the first testicle transplant, in the 70’s and now in the current century, the world’s first ovary transplant. He was the first to develop the TESE and MESA techniques for retrieving testicular and epididymal sperm in azoospermic men. He headed the clinical MIT team that first mapped and sequenced the Y chromosome in infertile men and discovered the now famous DAZ gene for male fertility. His research includes also the study of reproduction and fertility in zoo animals and endangered species. Most recently he has perfected the preservation of fertility for cancer patients with ovarian freezing and transplantation and thereby figured out how to extend the reproductive biological clock of women. He has helped pioneer minimal ovarian stimulation to reduce IVF costs and eliminate complications while maintaining the very highest success rate, even in older women. He has even recently answered the age-old question of why the dinosaurs went extinct by extending his research on male infertility and the Y chromosome, discovering that the change in earth temperature 65,000,000 years ago led to the birth of a skewed male/female sex ratio.
He now heads the clinical team on the CHOSE project to transform skin biopsy cells into eggs and sperm in humans.
Dr. Silber went to medical school at the University of Michigan, did post-graduate training at Stanford University, and then again at the University of Michigan. From 1967 to 1969, he provided medical care via the U. S. Public Health Service to Eskimos, Indians, and Aleuts. Then he taught at the University of Melbourne Medical School in Australia, and later at the University of California Medical School in San Francisco. He is a scientific collaborator at MIT in Cambridge, Massachusetts, at the Kato Clinic in Tokyo, and at the University of Kyushu in Japan, and is a full professor at the University of Amsterdam, and at Sun Yat Sen University Medical School in China. His major clinical medical practice is in St. Louis, Missouri.
Shinji Oono
TBD
Takehiko Ogawa
Yokohama City University, Japan
Takehiko Ogawa, MD, PhD
1985: Graduated from Yokohama City University School of Medicine.
1989: Earned a Ph.D. from Yokohama City University Graduate School of Medicine, majoring in Pathology with a focus on chemical carcinogenesis.
1989-1995: Worked as a Urologist at several hospitals in Yokohama City, Japan.
1995~1998: Post-doctoral researcher at Dr. Brinster’s lab in School of veterinary medicine, University of Pennsylvania, USA
1998~2012: Urologist and faculty at Yokohama City University Graduate School of Medicine
2013-2016: Professor at the Laboratory of Proteomics, Institute of Molecular Medicine and Life Science, Yokohama City University Association of Medical Science.
2017~2020: Professor at the Laboratory of Regenerative Sciences, Institute of Molecular Medicine and Life Science, Yokohama City University Association of Medical Science
2021~: Professor at the Department of Regenerative Medicine, Graduate School of Medicine, Yokohama City University
Terri L Woodard
The University of Texas MD Anderson Cancer Center Baylor College of Medicine, USA
Terri L Woodard
Dr. Terri L. Woodard is an Associate Professor in the Department of Gynecologic Oncology and Reproductive Medicine and Director of Oncofertility Program at the University of Texas MD Anderson Cancer Center.  She also holds a joint appointment in the Division of Reproductive Endocrinology and Infertility at the Baylor College of Medicine. She received her medical degree from the University of Pittsburgh School of Medicine and then completed her residency in Obstetrics and Gynecology at the Case Western Reserve MetroHealth and Cleveland Clinic Foundation Program. She completed her fellowship in Reproductive Endocrinology and Infertility at Wayne State University, where she then stayed on as faculty until moving to Houston, Texas.
Dr. Woodard arrived to Houston in 2012 to start the MD Anderson Oncofertility program in conjunction with Baylor College of Medicine/Texas Children’s Hospital. This program offers comprehensive fertility and family building services to men and women who have been diagnosed with cancer.  Her research interests include tracking oncologic and reproductive outcomes and exploring ways to educate and support women as they make decisions about fertility preservation.  Her decision aid, Pathways earned a Hermes Gold Award.  She is a recipient of a NCCN Young Investigator Award. She has also served as an educational resource, providing testimony for legislative bills supporting fertility preservation in the state of Texas.
Tommaso Falcone
Obstetrics, Gynecology and Reproductive Biology, Cleveland Clinic Lerner College of Medicine, USA
Tommaso Falcone
Tommaso Falcone, M.D
Tommaso Falcone, M.D., FRCS(C), FACOG, FRCOG (ad eundem) is Professor of Obstetrics, Gynecology and Reproductive Biology, at the Cleveland Clinic Lerner College of Medicine. Dr. Falcone received his medical degree from McGill University School of Medicine in Montreal, Quebec, Canada. While at McGill, he went on to complete a residency in obstetrics and gynecology and a fellowship in reproductive endocrinology.
Dr. Falcone was appointed Chair of the department of obstetrics & Gynecology in 2001 and subsequently Chair of the Women’s health institute in 2008 to 2018.
From 2018-2022 he served as Chief of Staff, Chief Academic Officer, Medical Director Cleveland Clinic London. In 2022 to 2023 he served as Interim Chief Executive Officer CCL where he lead the transition f rom a design phase- start up to an operational hospital.
He was a member of the board of governors of Cleveland Clinic between 2006-2013, member of the Executive Team (ET) from 2007-2010 and 2023. He served as Vice Chairman of Professional Staff Affairs, Cleveland Clinic from 2007-2014.
Dr. Falcone has published more than 500 original manuscripts, abstracts, and book chapters. He is co-editor of 8 books including a textbook on Clinical Reproductive Medicine and Surgery (Springer 4th edition 2022).
He has served on the editorial board of several journals, including Associate Editor of Fertility & Sterility and the Editorial Board of the Obstetrics &Gynecology (Green journal). He was editor-in-chief of JMIG from 2013-2023. He is past President of the Society for Reproductive Surgeons (SRS) and Past Chair of the Endometriosis special interest group of the ASRM. He is Past President of the International Society for Fertility Preservation (ISFP-2019-2020). He has served on review committees for NICHD and MRC. Dr. Falcone has been the recipient of many awards for laparoscopic and robotic surgery at different societies. He was a senior author on the first publication on gynecologic robot surgery and a member of the team that performed the first uterus transplant in the USA.

DOI:10.1016/j.jmig.2023.04.003

DOI:10.1016/j.jogoh.2019.05.001

DOI:10.1016/j.jmig.2018.01.016

Wen Li
The International Peace Maternity and Child Health Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China
Wen Li
Professor Li, the Director of the Reproductive Medicine Center at the International Peace Maternity & Child Health Hospital and Chairman of the Chinese Fertility Preservation Society, also serves as the Vice President of the Asian Society for Fertility Preservation, specializes in diagnosis and management of reproductive endocrine diseases and application of assisted reproductive technology. Her research is focused on fertility preservation of POI and cancer patients. Her significant contribution includes leading China’s first successful live birth after ovarian cryopreservation.

DOI:10.1002/advs.202304113

DOI:10.1093/procel/pwac043

DOI:10.1038/s41421-021-00372-0

DOI:10.1016/j.isci.2021.102065

DOI:10.1038/s41419-021-04016-9

DOI:10.1038/s41467-019-12935-7

DOI:10.1016/j.celrep.2021.108897

DOI:10.1039/c9bm00651f

DOI:10.1038/s41419-019-1995-1

Yichun Guan
Center for Reproductive Medicine, The Third Affiliated Hospital of Zhengzhou University, China
Yichun Guan
Guan, Yi Chun, MD, PhD
Department of Reproductive Medicine
The Third Affiliated Hospital of Zhengzhou University in China
HIGHLIGHT OF QUALIFICATIONS
Professional Skills
• 4 years of working experiences in department of Obstetrics and Gynecology, can skilled manipulate all basic operations, such as Cesarean Section, Hysterectomy, etc.
• 18 years of working experiences in the field of Reproductive Medicine.
• Extensive training and research experience in Molecular Biology, Fertility Preservation, Genetics and Embryology.
• Good oral and written skills.
EDUCATION
Master
Reproduction. Zhengzhou University. September, 2004-July, 2007
Course work:
Basic theory of Reproductive endocrinology, Molecular biology, Genetics, Embryology, Molecular biology of genes, Obstetrics and Gynecology, Professional English, Proteomics, Immunology, etc.
Ph.D
Reproduction. Zhengzhou University. September, 2011-2016
Course work:
Obstetrics and Gynecology, Embryology, Biochemistry, Physiology, Pathology, Pathophysiology, Medical Immunology, Endocrinology Pain, Oral English, Academic writing, Bioinformatics, etc.
Yodo Sugishita
Department of Obstetrics and Gynecology, St. Marianna University School of Medicine, Japan
Yodo Sugishita
Young sik Choi
Yonsei University College of Medicine, Korea
Young sik Choi
Young Sik Choi, MD., Ph.D. earned his medical degree and doctorate in philosophy from the College of Medicine, Seoul National University, and completed residency training in Obstetrics and Gynecology, followed by a fellowship in Reproductive Endocrinology and Infertility at Seoul National University Hospital. Currently serving as a Professor in the Department of Obstetrics and Gynecology at Yonsei University College of Medicine, Seoul, Korea, Dr. Choi is renowned for his expertise in reproductive medicine. He has published peer-reviewed scientific articles over one hundred in the fields of reproductive and endocrinology and infertility. His specific research interest is the application of regenerative medicine in the field of reproduction. He serves as the associate editor of the Journal of Korea Medical Science and the journal “Clinical and Experimental Reproductive Medicine” and a chair of the Scientific Committee of the Korean Society for Reproductive Medicine and the Korean Society of Assisted Reproduction.

DOI:10.1126/sciadv.abe8873

DOI:10.1007/s00441-021-03415-w

DOI:10.1007/s43032-020-00445-7

Zev Rosenwaks
Weill Cornell Medicine-the Ronald O. Perelman and Claudia Cohen Center for Reproductive Medicine, USA
Zev Rosenwaks
Zev Rosenwaks, M.D., is the Director and Physician-in-Chief of the Ronald O. Perelman and Claudia Cohen Center for Reproductive Medicine at Weill Cornell Medical College and NewYork-Presbyterian Hospital and the Director of the Institute for Reproductive Medicine. He is a Professor of Obstetrics and Gynecology and Reproductive Medicine at Weill Cornell Medical College and an Attending Obstetrician-Gynecologist at NewYork-Presbyterian Hospital. In 1994, Dr. Rosenwaks was named the Revlon Distinguished Professor of Reproductive Medicine in Obstetrics and Gynecology.
Dr. Rosenwaks is internationally renowned for his pioneering work in reproductive endocrinology and assisted reproduction. He was the Director of the Jones Institute for Reproductive Medicine in Norfolk, Virginia, the unit that achieved the first IVF pregnancy in the United States. He also developed the first egg donation program in the United States. Dr. Rosenwaks has been recognized in New York Magazine's "Best Doctors in New York, the Northeast," as well as in Castle Connolly's guide to America's Top Doctors. He has also been featured in interviews with various major media outlets and newspapers.
Currently, Dr. Rosenwaks serves as a Fellow on the Weill Cornell Medical College Board of Fellows and is a member of the Executive Faculty Council. He served as Vice Chairman of the Board of Directors of The Howard and Georgeanna Jones Foundation for Reproductive Medicine and was a member of the Institute of Medicine's Committee on Assessing the Medical Risks of Human Oocyte Donation for Stem Cell Research and the World Health Organization's Task Force on Prevention and Management of Infertility. Dr. Rosenwaks has trained over 90 national and international fellows and has been honored with the Maurice R. Greenberg Distinguished Service Award, the highest honor bestowed by NewYork-Presbyterian Hospital/Weill Cornell Medical Center on a member of its professional staff. He has also been a recipient of the Weill Cornell Medical College Award for Teaching Excellence and the American Society for Reproductive Medicine Lifetime Achievement Award.
Dr. Rosenwaks is board certified in both Obstetrics and Gynecology and Reproductive Endocrinology and Infertility. He is a fellow of the American College of Obstetricians and Gynecologists and is past President of several esteemed organizations, including the Society for Reproductive Endocrinology, the Society for Assisted Reproductive Technology, the International Society for In Vitro Fertilization, and the New York Obstetrical Society. Currently, he is the American Representative of the International Federation of Gynecology and Obstetrics (FIGO) Committee for Reproductive Medicine. He is also a member of the Board of Directors of the International Society for Fertility Preservation and serves on the Scientific Advisory Committee for the Center for Embryonic Cell and Gene Therapy at Oregon Health & Science University (OHSU).
Dr. Rosenwaks has an extensive publication record, including over 500 peer-reviewed articles, more than 130 book chapters and invited publications, and eight textbooks. Some notable works include In Vitro Fertilization-Norfolk (Williams & Wilkins, 1986); Gynecology: Principles and Practice (Macmillan and Co., 1987); Nonsteroidal Gonadal Factors: Physiological Roles and Possibilities in Contraceptive Development (The Jones Institute Press, 1988); Reproductive Endocrinology, Surgery, and Technology (Lippincott-Raven, 1996); Reproductive Medicine Secrets (Hanley & Belfus, 2004); co-author of A Baby at Last (Simon & Schuster, 2010); and co-editor of Problem-Focused Reproductive Endocrinology and Infertility (Springer, 2023). Dr. Rosenwaks has also served as an Associate Editor of the Journal of Assisted Reproduction and Genetics, and Seminars in Reproductive Medicine and as Editorial Editor of Fertility and Sterility.